Skip to content

Erasca

US · ERAS #2103 by market cap Listed 2021
13.61 -0.61 -4.29%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Erasca

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Founded
2018
CEO
Dr. Jonathan E. Lim,M.D.
Employees
103
Headquarters
San Diego, California, United States of America
Fiscal year end
12-31
Website
erasca.com

Company profile

Exchange
US
Symbol
ERAS
Market-cap rank
#2103
Listing date
2021-07-16
Market cap
4.78B
Float cap
3.34B
Shares out
350.96M
Float shares
245.21M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Erasca discussion 0 comments

Add a comment